John Overdeck’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,839
| Closed | -$31K | – | 5423 |
|
|
2026
Q1 | $31K | Sell |
10,839
-7,749
| -42% | -$23.2K | ﹤0.01% | 4495 |
|
|
2025
Q4 | $60K | Buy |
+18,588
| New | +$60.1K | ﹤0.01% | 3915 |
|
|
2024
Q1 | – | Sell |
-2,010
| Closed | -$21.3K | – | 3384 |
|
|
2023
Q4 | $21.3K | Sell |
2,010
-51
| -2% | -$614 | ﹤0.01% | 3051 |
|
|
2023
Q3 | $40.8K | Sell |
2,061
-717
| -26% | -$30.9K | ﹤0.01% | 2832 |
|
|
2023
Q2 | $213K | Sell |
2,778
-3,762
| -58% | -$304K | ﹤0.01% | 2628 |
|
|
2023
Q1 | $618K | Sell |
6,540
-4,372
| -40% | -$416K | ﹤0.01% | 2108 |
|
|
2022
Q4 | $1.06M | Buy |
10,912
+8,066
| +283% | +$1.17M | ﹤0.01% | 1665 |
|
|
2022
Q3 | $734K | Sell |
2,846
-226
| -7% | -$65.6K | ﹤0.01% | 1598 |
|
|
2022
Q2 | $571K | Sell |
3,072
-8,812
| -74% | -$842K | ﹤0.01% | 1775 |
|
|
2022
Q1 | $1.16M | Sell |
11,884
-5,651
| -32% | -$725K | ﹤0.01% | 1642 |
|
|
2021
Q4 | $2.87M | Buy |
17,535
+14,498
| +477% | +$3.19M | 0.01% | 1608 |
|
|
2021
Q3 | $829K | Sell |
3,037
-2,462
| -45% | -$753K | ﹤0.01% | 2788 |
|
|
2021
Q2 | $2.18M | Sell |
5,499
-971
| -15% | -$453K | ﹤0.01% | 1786 |
|
|
2021
Q1 | $3.49M | Buy |
6,470
+764
| +13% | +$476K | 0.01% | 1289 |
|
|
2020
Q4 | $2.16M | Buy |
5,706
+589
| +12% | +$234K | 0.01% | 1448 |
|
|
2020
Q3 | $1.93M | Buy |
5,117
+5,005
| +4,469% | +$2.21M | 0.01% | 1312 |
|
|
2020
Q2 | $55K | Sell |
112
-2,870
| -96% | -$1.28M | ﹤0.01% | 2836 |
|
|
2020
Q1 | $1.1M | Buy |
2,982
+2,132
| +251% | +$1.1M | 0.01% | 1340 |
|
|
2019
Q4 | $602K | Buy |
850
+145
| +21% | +$99.8K | ﹤0.01% | 2639 |
|
|
2019
Q3 | $453K | Buy |
+705
| New | +$559K | ﹤0.01% | 2639 |
|
|
2019
Q1 | – | Sell |
-756
| Closed | -$212K | – | 3454 |
|
|
2018
Q4 | $212K | Buy |
+756
| New | +$299K | ﹤0.01% | 2679 |
|
|
2015
Q3 | – | Sell |
-460
| Closed | -$827K | – | 2713 |
|
|
2015
Q2 | $827K | Sell |
460
-1,472
| -76% | -$2.29M | ﹤0.01% | 1786 |
|
|
2015
Q1 | $3.12M | Buy |
+1,932
| New | +$2.86M | 0.01% | 940 |
|
|
2014
Q2 | – | Sell |
-217
| Closed | -$149K | – | 2346 |
|
|
2014
Q1 | $149K | Buy |
+217
| New | +$145K | ﹤0.01% | 1845 |
|
Other funds holding TCRT
TRCT
AAP
John Overdeck's TCRT Position: Q2 2026 in Review
John Overdeck sold out of Alaunos Therapeutics (TCRT) in Q2 2026, closing a stake of 10,839 shares — an estimated $31K sold.
John Overdeck first reported a position in TCRT in Q1 2014 and held it in 24 quarters. The position peaked at $3.49M in Q1 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.
- John Overdeck reported no remaining Alaunos Therapeutics position as of Q2 2026 after selling out during the quarter.
- John Overdeck sold 10,839 Alaunos Therapeutics shares in Q2 2026, an estimated $31K.
- John Overdeck first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 24 quarters.
- John Overdeck's Alaunos Therapeutics position peaked at $3.49M in Q1 2021.
- 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.